Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Joseph Capper becomes new CardioNet CEO

This article was originally published in Clinica

Executive Summary

Cardiac arrhythmia specialist CardioNet has employed Joseph Capper as its president and CEO. Mr Capper was previously president and CEO of diabetes management firm Home Diagnostics and medical supplies company CCS Medical. He also used to work for Bayer as national sales director of the group’s diabetic products division. Mr Capper replaces Randy Truman who will remain on CardioNet’s board of directors. Conshohocken, Pennsylvania-based CardioNet specialises in the diagnosis and monitoring of heart rhythm disorders with its mobile cardiac outpatient telemetry (MCOT).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT094925

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel